首页> 美国卫生研究院文献>Nanoscale Research Letters >New Method to Prepare Mitomycin C Loaded PLA-Nanoparticles with High Drug Entrapment Efficiency
【2h】

New Method to Prepare Mitomycin C Loaded PLA-Nanoparticles with High Drug Entrapment Efficiency

机译:高载药率制备丝裂霉素C负载PLA纳米颗粒的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The classical utilized double emulsion solvent diffusion technique for encapsulating water soluble Mitomycin C (MMC) in PLA nanoparticles suffers from low encapsulation efficiency because of the drug rapid partitioning to the external aqueous phase. In this paper, MMC loaded PLA nanoparticles were prepared by a new single emulsion solvent evaporation method, in which soybean phosphatidylcholine (SPC) was employed to improve the liposolubility of MMC by formation of MMC–SPC complex. Four main influential factors based on the results of a single-factor test, namely, PLA molecular weight, ratio of PLA to SPC (wt/wt) and MMC to SPC (wt/wt), volume ratio of oil phase to water phase, were evaluated using an orthogonal design with respect to drug entrapment efficiency. The drug release study was performed in pH 7.2 PBS at 37 °C with drug analysis using UV/vis spectrometer at 365 nm. MMC–PLA particles prepared by classical method were used as comparison. The formulated MMC–SPC–PLA nanoparticles under optimized condition are found to be relatively uniform in size (594 nm) with up to 94.8% of drug entrapment efficiency compared to 6.44 μm of PLA–MMC microparticles with 34.5% of drug entrapment efficiency. The release of MMC shows biphasic with an initial burst effect, followed by a cumulated drug release over 30 days is 50.17% for PLA–MMC–SPC nanoparticles, and 74.1% for PLA–MMC particles. The IR analysis of MMC–SPC complex shows that their high liposolubility may be attributed to some weak physical interaction between MMC and SPC during the formation of the complex. It is concluded that the new method is advantageous in terms of smaller size, lower size distribution, higher encapsulation yield, and longer sustained drug release in comparison to classical method.
机译:用于将水溶性丝裂霉素C(MMC)封装在PLA纳米颗粒中的经典利用的双乳液溶剂扩散技术由于药物快速分配到外部水相而遭受了低的封装效率。本文采用一种新的单乳液溶剂蒸发法制备了载有MMC的PLA纳米颗粒,其中采用大豆磷脂酰胆碱(SPC)通过形成MMC–SPC复合物来改善MMC的脂溶性。基于单因素测试结果的四个主要影响因素,即PLA分子量,PLA与SPC的比例(wt / wt)和MMC与SPC的比例(wt / wt),油相与水相的体积比,使用正交设计对药物包封效率进行评估。药物释放研究是在37°C的pH 7.2 PBS中进行的,使用365 nm的紫外/可见光谱仪进行药物分析。采用经典方法制备的MMC-PLA颗粒作为比较。发现在优化条件下配制的MMC–SPC–PLA纳米颗粒尺寸相对均匀(594 nm),具有高达94.8%的药物截留效率,而PLA–MMC微粒为6.44μm,具有34.5%的药物截留效率。 MMC的释放显示为双相的,具有最初的爆发效应,随后30天内累积的药物释放对于PLA–MMC–SPC纳米粒子为50.17%,对于PLA–MMC粒子为74.1%。对MMC-SPC复合物的IR分析表明,它们的高脂溶性可能归因于MMC和SPC在复合物形成过程中的某些较弱的物理相互作用。结论是,与传统方法相比,该新方法在较小的尺寸,较小的尺寸分布,较高的包封率和更长的药物释放方面是有利的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号